Skip to content

Static Progressive Splinting in the Management of Knee Stiffness Following Total Knee Arthroplasty

Static Progressive Splinting in the Management of Knee Stiffness Following Total Knee Arthroplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04837872
Enrollment
10
Registered
2021-04-08
Start date
2017-05-25
Completion date
2019-02-12
Last updated
2021-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Replacement, Knee

Keywords

static progressive splinting, manual therapy, physical therapy, rehabilitation, arthrofibrosis

Brief summary

The purpose of this study is to determine the feasibility and initial efficacy of static progressive splinting for individuals presenting with knee stiffness following total knee arthroplasty (TKA). Data from this trial will be utilized in a NIH grant application for a larger randomized controlled trial directly comparing static progressive splinting to manipulation under anesthesia (MUA) which is the current standard of care for knee stiffness after TKA.

Detailed description

Total knee arthroplasty (TKA) is the standard of care to manage the pain and disability associated with end-stage knee osteoarthritis, with more than 700,000 TKA surgeries performed annually in the United States. Knee stiffness, commonly caused by arthrofibrosis, is an infrequent, but debilitating complication of TKA, with an incidence upwards of 5% postoperatively. As a predominant failure mechanism, knee stiffness accounts for 28% of hospital readmissions due to surgical complications within 90 days of discharge, and 10% of all revisions within 5 years of initial surgery within the United States. With the incidence of TKA projected to reach 3.5 million by 2030, the growing cohort of TKA patients with postoperative knee stiffness provides an important target for research. Several treatments for knee stiffness have been described including static progressive splinting and manipulation under anesthesia (MUA). To date, no studies have compared the use of static progressive splinting in the early management of individuals presenting with knee stiffness after TKA to more commonly utilized surgical procedures such as MUA. Witvrouw and colleagues compared a computer-controlled passive motion device to MUA for individuals with knee stiffness after TKA and found that stretching device had similar outcomes to MUA in terms of range of motion (ROM) and self-reported pain, stiffness and function. A key limitation of this study is that the computer-controlled motion device is not commercially available and therefore translation of this technology into practice is unlikely. However, this study does demonstrate that conservative stretching techniques may be as efficacious as costlier surgical techniques as well as may cause fewer adverse events such as quadriceps tendon rupture and fractures. Only one study to date has examined the utilization of static progressive splinting after TKA. In this study, they enrolled patients who had already failed MUA and conservative physical therapy management strategies. They found that the average ROM increase for patients was 25° as well as 92% of patients were satisfied with the results and no complications occurred with use of the device. Key limitations to this study are the lack of a comparison group as well as static progressive splinting was utilized after MUA had already failed. It is unknown how individuals would respond to this treatment compared to MUA. Therefore, the purpose of our study is to determine the feasibility and initial efficacy of static progressive splinting for individuals presenting with knee stiffness following TKA within the current surgical practice of Dr. Jared Foran at Panorama Orthopedics & Spine Center. Data from this trial will be utilized in a NIH grant application for a larger randomized controlled trial directly comparing static progressive splinting to MUA which is the current standard of care for knee stiffness after TKA.

Interventions

OTHERMultimodal Physical Therapy (MPT)

Individualized physical therapy and static progressive splint (flexion with or without extension splint).

Sponsors

Panorama Orthopedics & Spine Center
CollaboratorINDUSTRY
University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Undergone a unilateral primary Total Knee Arthroplasty (TKA) for end-stage osteoarthritis * Knee stiffness in the first 6 weeks post-operative defined as knee flexion \< 100 degrees

Exclusion criteria

* Preoperative knee range of motion less than 15-110 degrees * Intraoperative (closed) range of motion \< 0-120 degrees * Radiographic signs of heterotopic ossification * Misaligned components or component-related failures of knee prosthesis that could be responsible for difficulties with motion * Signs and symptoms consistent with joint infection * Signs and symptoms consistent with complex regional pain syndrome

Design outcomes

Primary

MeasureTime frameDescription
Range of Motion4 weeksPassive knee flexion and extension measured with goniometry

Secondary

MeasureTime frameDescription
Adherence to Splint Use4 weeksAdherence to splint use was tracked with a log completed by participants; they were instructed to place a checkmark for each day they used the JAS splint per protocol (30-minute sessions, 3 times daily). Adherence was calculated as days of splint use completed divided by days of splint use prescribed; a priori adherence levels were considered acceptable if the mean was ≥ 80 percent.
Satisfaction with Splint4 weeksSatisfaction was assessed with a 7-point Likert scale ranging from 1 extremely dissatisfied to 7 extremely satisfied. Participants responded based on the following instruction: please rate your satisfaction with your knee splint on the scale. A priori satisfaction was considered acceptable if the median score was ≥ 4 (somewhat satisfied or higher).
Safety of splint use: adverse events4 weeksCount and description of adverse events related to splint use

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026